SITAGLIPTIN - METFORMIN
SITAGLIPTIN - METFORMIN
Approved
Approval ID
f9519812-a5b0-1a19-e053-6294a90a471d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 14, 2023
Manufacturers
FDA
Truemed Group LLC
DUNS: 004154534
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SITAGLIPTIN - METFORMIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code82922-100
Product Classification
G
Generic Name
SITAGLIPTIN - METFORMIN
Product Specifications
Route of AdministrationORAL
Effective DateApril 14, 2023
FDA Product Classification
INGREDIENTS (2)
METFORMINActive
Quantity: 850 mg in 1 1
Code: 9100L32L2N
Classification: ACTIB
SITAGLIPTINActive
Quantity: 50 mg in 1 1
Code: QFP0P1DV7Z
Classification: ACTIB